Learning and research

User account menu

Join
Log in

Main navigation

Upcoming events
Learning and research
IDDI Workstreams & Task Forces
Membership
Pulmonary hypertension
Support us
About us

User account menu

Join
Log in

Breadcrumb

Home
Learning and Research

Pagination

Previous page
Page 8

Related content

GoDeep Global PH Registry
Pulmonary Circulation
Pulmonary Hypertension Global Patient Survey (PH GPS)
Latest news

Fulltext search

Reset filters

Fulltext search

Publication Types

Pulmonary Circulation
IDDI Workstream or Task Force Learning
PVRI Digital Webinar Series
PVRI Community Calls
PVRI 2025 Rio
PVRI 2024 London
PVRI 2023 DDDS
PVRI 2022 Athens

Subjects

Basic research and pathophysiology
- Cellular and molecular biology
- Extra-pulmonary vascular cell and tissue types
- Genetics/genomics and other Omics
- Immunology and inflammation
- Infections and PVD
- Right ventricle
Diagnostic and assessment methods
- 1MWT, 6MWT, Incremental shuttle walk test
- Biomarkers
- Cardiopulmonary exercise test
- Genetic markers
- Hemodynamic assessments
- Imaging techniques
- Pulmonary function test
Diseases and clinical manifestations
- Group 1: Pulmonary Arterial Hypertension (PAH)
- Group 2: PH associated with left heart disease
- Group 3: PH associated with lung disease and/or hypoxia
- Group 4: PH associated with pulmonary artery obstruction / CTEPH
- Group 5: PH with unclear and/or multifactorial mechanisms
- Paediatric PH
Emerging trends and future research
- Emerging therapies
- Novel clinical trial designs in PH
- Policy and guidelines
- Technological advances
Epidemiology and public health
- Global health and PH
- Incidence, prevalence, and risk factors
- Population studies and public health initiatives
Patient care and advocacy
- Advocacy and quality of life improvement
- Palliative care in PH
- Psychosocial aspects and patient education
- Special circumstances
- Symptom management
Treatment
- Perioperative care
- PH-specific therapies
- Special populations
- Supportive therapy
- Surgical and interventional procedures

1 February 2024

Conceptualising PH through a global lens

Presented at PVRI 2024 Congress by Sue Goldie

PVRI 2024 London

1 February 2024

iPVD Consortium: When HIV meets schistosoma: immune & non-immune determinants of PV pathology

Presented at PVRI 2024 Congress by Angel Cogolludo, Universidad Complutense de Madrid

Members Only

Member content

1 February 2024

IDDI Real World Evidence Workstream - Current state & future opportunities in PH

Presented at PVRI 2024 Congress by Raymond Benza, Icahn School of Medicine at Mount Sinai

Members Only

Member content

1 February 2024

Creating a "digital twin" for evaluation and management of PAH

Presented at PVRI 2024 Congress by Pablo Lamata, Kings College London

Members Only

Member content

1 February 2024

Platelet RNAs for the detection of cancer and PH

Presented at PVRI 2024 Congress by Myron Best, Amsterdam UMC University Medical Center

Members Only

Member content

31 January 2024

PVRI President's welcome to PVRI 2024 Congress

Presented at PVRI 2024 Congress 'The next 50 years of pulmonary hypertension - a global view' by Kurt Stenmark, University of Colorado

Members Only

Member content

Pagination

First page First

Previous page Previous

…

Page 6

Page 7

Page 8

Current page 9

Footer Menu

GET LEARNING
- Attend an event
- Keep up with PVD developments
GET CONNECTED
GET INVOLVED

Footer menu - pages

Accessibility
Code of Conduct
Complaints
Cookies & Privacy Policy
Social Media Policy
Terms & Conditions

The Pulmonary Vascular Research Institute (PVRI) is a charity registered in England & Wales no. 1127115 and a Company Limited by Guarantee no. 05780068. VAT registration no. 488 0247 66. Registered office: 5 Tanner Street, London SE1 3LE. Phone number: + 44 (0) 7934 126930.

Translate this page